Rhopressa “Now Approved” Website for HCPs Jan 29, 2018Jan 22, 2018 Brand: Rhopressa (netarsudil), Ophthalmic Solution Parent Company: Aerie Pharmaceuticals Drug Type: Prescription Drug Category: Ophthalmology Campaign: now-approved Targeting: HCPs Patient Website: HCP Website: https://rhopressa.com/ Full Scroll Unmet Need MOA Treatment Option One of the most beautiful Now Approved websites out there.